NEW YORK, Sept 20 (Reuters) – Mylan NV faced new
scrutiny over price hikes for its anti-allergy EpiPen on
Tuesday, with U.S. lawmakers calling for a probe of oversight of
the company’s rebates to…
The post UPDATE 4-Senate Republicans seek probe of Mylan EpiPen oversight appeared first on NASDAQ.